News

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
COVID-19 vaccine protection fades within months due to a lack of long-lived plasma cells. Booster shots restore some immunity ...
The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.
FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...
An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...
The Food and Drug Administration is adjusting the standard of evidence needed for shots to be approved by the general public.
FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...
The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.